The ISSDP Excellence in Research Award
Goal
To recognize a piece of research published in the past 3 years that has made a substantial innovation in how we think about or conduct research in the area of drug policy, including (but not exclusively limited to) the methods and data used for conducting drug policy analysis, the theoretical models of or frameworks guiding work on the agents (consumers, suppliers, regulators) or systems (drug markets, health providers, criminal justice system, social services) that influence drug policy, and/or practical understanding of drug policy in the world today.
Award
The selected individual will receive a formal certificate from the society, a monetary award of $3000 US plus $500 in travel expenses, as well as the opportunity to give a 30-minute presentation at the annual ISSDP meeting.
Eligibility criteria
- English-language publication (article, book, or report)
- Can be authored by an ISSDP member or a non-ISSDP member
- If the publication has multiple authors, they will have to choose one person to come to the meeting and accept the award
- Published in the last three years (since January 1 of the year of the ISSDP Conference). For 2024, this if from January 2021 to December 2023.
Nominations and Committee
Anyone who wishes to nominate a paper for consideration (self-nominations are welcome) should send their nominations to Peter Reuter (preuter@umd.edu) by March 31, 2024. The Committee reserves the right to nominate papers. The decision of the committee will be announced electronically by April 15, 2024
The committee consists of:
Peter Reuter, University of Maryland (preuter@umd.edu)
Alison Ritter, University of New South Wales (Alison.ritter@unsw.edu.au)
Alex Stevens, University of Kent (a.w.stevens@kent.ac.uk)
Best presentation by an early career scholar at the ISSDP conference
Nominations for the best presentation can be made by any early career scholar who is presenting at the ISSDP conference.
Criteria:
- Presentation at the ISSDP conference
- First author is within five years of her/his PhD (or last degree)
- The presentation represents outstanding and unique drug policy research
Selection process:
The presentations will be judged at the conference by the ISSDP Board members present, and announced at the closing of the annual conference.
Early Careers Researcher winners
Each year the ISSDP Board provides an award to the best early career researcher presentation at the annual scientific conference. (Awards did not run during COVID-19). The past winners are:
2024: Parker Tope, McGill University, Canada, for her paper ‘Systematic Review and Meta-Analysis on the Impact of Opioid Prescribing Guidelines for Opioid Prescription Initiations and Discontinuations.’
2019: Jack Spicer, University of the West of England, Bristol, for his paper ‘Between gang talk and prohibition: scapegoating and the transfer of responsibility for County Lines‘.
2019: Jack Spicer, University of the West of England, Bristol, for his paper ‘Between gang talk and prohibition: scapegoating and the transfer of responsibility for County Lines‘.
2018: Kari Lancaster, UNSW Australia, for her paper ‘A more accurate understanding of drug use: A critical analysis of wastewater analysis technology for drug policy‘.
2017: Bryce Pardo, University of Maryland, for his paper ‘What relationship does access to cannabis have on the consumption of synthetic cannabinoids?‘.
2016: Thu Vuong, UNSW Australia, for her paper ‘Economic Evaluation comparing Centre-based Compulsory Drug Rehabilitation with Community-based Methadone Treatment in Hai Phong City, Vietnam‘.
2015: Laura Atuesta, Drug Policy Program, Centro de Investigacion Docencia Economicas (CIDE), Mexica, with her paper entitled ‘Narco-messages’ as a way to analyse the evolution of organised crime in Mexico‘.
2014: Lolitha Jaikar, Stella Maris College, India and International Federation of Catholic Universities, France with her paper entitled ‘Policies and practices of drug use in india: a situational analysis‘.
2013: Sandra Rozo, UCLA with her paper entitled ‘How are anti-drug programs affecting producers? Evidence from coca leaf production in Colombia‘.
